Diabetic Neuropathy

Stem cells from bone marrow are being investigated as possible treatments for diabetic neuropathy. Click on the link provided to find out more about each trial. It remains too early to know which approach will be most suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Diabetic Neuropathy

  • Effect of Mesenchymal Stem Cells Transplantation to Improve of Diabetic Neuropathy Location: Iran
    Overview: This trial aims to evaluate the use of the patient's own mesenchymal stem cells in the treatment of neuropathy in patients with type 1 diabetes. The trial is being conducted by the Endocrinology and Metabolism Research Institute in Teheran and proposes to recruit 20 patients by end 2013. The participants will receive an intravenous (IV) infusion of mesenchymal stem cells that have been obtained from their own bone marrow and expanded in the laboratory. Participants will be monitored for complications and changes in their condition, including sensory neurological evaluation and blood glucose control.
    Link to Clinical Registry
    Trial Design: Observational Study
    Status: Open - Recruiting
    Stem Cell: Adult Bone Marrow Stem Cells
  • Safety and Efficacy Study of Autologous Bone Marrow Stem Cell Transplantation for the Treatment of Diabetic Neuropathy Location: China
    Overview: This trial aims to investigate whether stem cells from the patient's own bone marrow can improve neurological function in diabetic neuropathy. The trial is being conducted by Central Hospital of Wuhan; Tongji Medical College, and Huazhong University of Science and Technology and seeks to enrol 100 patients. Participants will be randomly divided into either a group that only receives conventional treatment for diabetes (control group), and another groups that will receive an infusion of stem cells obtained from the patient's own bone marrow. Participants will be monitored for complications and changes in clinical condition. The trial is scheduled to run from October 2010 to December 2013.
    Link to Clinical Registry
    Trial Design: Therapeutic intervention
    Status: Open - Recruiting
    Stem Cell: Adult Bone Marrow Stem Cells